Literature DB >> 20698352

Expression of redox pathway enzymes in human prostatic tissue.

Alexander Valdman1, Lars Häggarth, Liang Cheng, Antonio Lopez-Beltran, Rodolfo Montironi, Peter Ekman, Lars Egevad.   

Abstract

OBJECTIVE: To evaluate the involvement of thioredoxin reductase (TxnR), thioredoxin (Trx) and peroxiredoxins (Prdx) in prostate cancer (PCa) and to assess the potential prognostic importance of these redox-regulated pathways. STUDY
DESIGN: Expression of the isoforms TxnR2, Trx1 and Prdx2 was studied by immunohistochemistry on tissue microarrays (TMAs). In a prognostic TMA, 294 primary cases of PCa with a median follow-up of 49 months were stained for Trx1 and Prdx2. Another TMA containing benign prostatic tissue, atrophy, high grade prostatic intraepithelial neoplasia (HGPIN) and PCa from 40 patients was stained with all 3 antibodies. RES ULTS: All 3 proteins showed similar expression patterns, with the highest immunoreactivity in HGPIN followed by atrophy, PCa and benign tissue. TxnR2, Trx1 and Prdx2 were overexpressed in HGPIN and PCa compared with benign tissue (p < 0.001), and Trx1 and Prdx2 were also overexpressed in HGPIN compared with PCa (p < 0.001). Trx1 and Prdx2 did not correlate with biochemical recurrence.
CONCLUSION: This study demonstrates up-regulation of the redox pathway proteins in PCa and its precursor lesions. The pathogenetic role of the redox system remains to be investigated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20698352

Source DB:  PubMed          Journal:  Anal Quant Cytol Histol        ISSN: 0884-6812            Impact factor:   0.302


  6 in total

1.  Knockout of mitochondrial thioredoxin reductase stabilizes prolyl hydroxylase 2 and inhibits tumor growth and tumor-derived angiogenesis.

Authors:  Juliane Hellfritsch; Julian Kirsch; Manuela Schneider; Tamara Fluege; Markus Wortmann; Jeroen Frijhoff; Markus Dagnell; Theres Fey; Irene Esposito; Pirkko Kölle; Kristin Pogoda; José Pedro Friedmann Angeli; Irina Ingold; Peter Kuhlencordt; Arne Östman; Ulrich Pohl; Marcus Conrad; Heike Beck
Journal:  Antioxid Redox Signal       Date:  2015-04-10       Impact factor: 8.401

2.  Intra- and interobserver reproducibility of interpretation of immunohistochemical stains of prostate cancer.

Authors:  Sara Jonmarker Jaraj; Philippe Camparo; Helen Boyle; François Germain; Bo Nilsson; Fredrik Petersson; Lars Egevad
Journal:  Virchows Arch       Date:  2009-09-18       Impact factor: 4.064

3.  Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging.

Authors:  Tyler M Bauman; Emily A Ricke; Sally A Drew; Wei Huang; William A Ricke
Journal:  J Vis Exp       Date:  2016-04-08       Impact factor: 1.355

4.  Peroxiredoxin 2 is upregulated in colorectal cancer and contributes to colorectal cancer cells' survival by protecting cells from oxidative stress.

Authors:  Weidong Lu; Zhongxue Fu; Hao Wang; Jihong Feng; Jinlai Wei; Jinbao Guo
Journal:  Mol Cell Biochem       Date:  2013-11-15       Impact factor: 3.396

Review 5.  Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling.

Authors:  Eva-Maria Hanschmann; José Rodrigo Godoy; Carsten Berndt; Christoph Hudemann; Christopher Horst Lillig
Journal:  Antioxid Redox Signal       Date:  2013-03-28       Impact factor: 8.401

6.  MicroRNA-122 negatively associates with peroxiredoxin-II expression in human gefitinib-resistant lung cancer stem cells.

Authors:  Nisansala Chandimali; Do Luong Huynh; Jiao Jiao Zhang; Jae Cheol Lee; Dae-Yeul Yu; Dong Kee Jeong; Taeho Kwon
Journal:  Cancer Gene Ther       Date:  2018-10-19       Impact factor: 5.987

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.